Literature DB >> 24003826

Mapping the Personality Psychopathology Five domains onto DSM-IV personality disorders in Dutch clinical and forensic samples: implications for DSM-5.

Martin Sellbom1, Wineke Smid, Hilde de Saeger, Naomi Smit, Jan H Kamphuis.   

Abstract

The Personality Psychopathology Five (PSY-5) model represents 5 broadband dimensional personality domains that align with the originally proposed DSM-5 personality trait system, which was eventually placed in Section III for further study. The main objective of this study was to examine the associations between the PSY-5 model and personality disorder criteria. More specifically, we aimed to determine if the PSY-5 domain scales converged with the alternative DSM-5 Section III model for personality disorders, with a particular emphasis on the personality trait profiles proposed for each of the specific personality disorder types. Two samples from The Netherlands consisting of clinical patients from a personality disorder treatment program (n = 190) and forensic psychiatric hospital (n = 162) were used. All patients had been administered the MMPI-2 (from which MMPI-2-RF PSY-5 scales were scored) and structured clinical interviews to assess personality disorder criteria. Results based on Poisson or negative binomial regression models showed statistically significant and meaningful associations for the hypothesized PSY-5 domains for each of the 6 personality disorders, with a few minor exceptions that are discussed in detail. Implications for these findings are also discussed.

Entities:  

Mesh:

Year:  2013        PMID: 24003826     DOI: 10.1080/00223891.2013.825625

Source DB:  PubMed          Journal:  J Pers Assess        ISSN: 0022-3891


  1 in total

1.  A Dimensional Understanding of Borderline Personality Disorder Using MMPI-2 PSY-5 Scales in Clinical Samples.

Authors:  Min Jin Jin; Hye-Jin Lee; Kyu-Sic Hwang; Jae-Hee Lee; Chan-Mo Yang; Seung-Ho Jang; Sang-Yeol Lee
Journal:  Psychiatry Investig       Date:  2021-12-08       Impact factor: 2.505

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.